Akèy › Kansè Poumon ki pa ti selil › Idaho › Meridian
Etid klinik pou Kansè Poumon ki pa ti selil nan Meridian, ID
4 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Meridian (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Saint Luke's Cancer Institute - Meridian, Meridian
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Ap rekriteFaz 2
- Idaho Urologic Institute-Meridian, Meridian
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Ap rekriteFaz 3
- Saint Luke's Cancer Institute - Meridian, Meridian
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Idaho Urologic Institute-Meridian, Meridian
- Saint Luke's Cancer Institute - Meridian, Meridian
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Meridian
- Obèsite8 etid
- Sipwa7 etid
- Kansè pwostat6 etid
- Leksemi mieloïd egi6 etid
- Ateroskleroz5 etid
- Kansè poumon4 etid
- Ensifizyans kadyak3 etid
- Kansè ovè3 etid
- Karsinòm selil skuamèz tèt ak kou3 etid
- Ekzema3 etid
- Maladi kadyovaskilè3 etid
- Kansè kolon3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.